CIK 0001907108 · <br>Emerging growth company
Lexeo Therapeutics, Inc.
Sign in to watch- Ticker
- LXEO
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 854012572
- Phone
- (212) 547-9879
- Business address
- 345 PARK AVENUE SOUTH, FLOOR 6, NEW YORK, NY, 10010
- 10-Q Report Quarterly Report
- 8-K Event Material agreement · Other events
- 8-K Event Executive or director change
- 8-K Event Other events
- 8-K Event Material agreement · Results of operations · Unregistered share sale · Regulation FD disclosure
- 10-K Report Annual Report
- 8-K Event Regulation FD disclosure
- 8-K Event Regulation FD disclosure
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 8-K Event Bylaws or fiscal year change
Page 3 of 3 · 51 filings